Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mind Medicine Mindmed Inc (MMEDF)

Mind Medicine Mindmed Inc (MMEDF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MMEDF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.0500 +128.78%
on 04/20/21
4.9900 -6.01%
on 04/26/21
+2.2000 (+88.35%)
since 03/26/21
3-Month
2.0500 +128.78%
on 04/20/21
4.9900 -6.01%
on 04/26/21
+1.1900 (+34.00%)
since 01/26/21
52-Week
0.2911 +1,511.13%
on 06/18/20
5.0700 -7.50%
on 12/14/20
+4.2317 (+923.35%)
since 04/24/20

Most Recent Stories

More News
This Company Believes Psilocybin Could be a Game-Changer for Obesity Treatment

With eating disorders, such as obesity bursting at the seams, NeonMind Biosciences (CSE:NEON)(OTC:NMDBF) ...

CYBN : 2.16 (-3.14%)
CLXPF : 3.0200 (-1.31%)
TRYP.CN : 0.400 (-1.23%)
MMEDF : 4.6900 (+33.24%)
CMPS : 33.14 (-0.66%)
NMDBF : 0.0811 (-3.34%)
NEON.CN : 0.105 (unch)
With Millions Suffering from Mental Health Issues, These Companies are Racing to Help

Millions of people all over the world are struggling with mental health issues. All thanks to the ...

RHT.VN : 0.890 (-2.20%)
RQHTF : 0.6988 (-1.63%)
MYCO.CN : 0.400 (-6.98%)
MYCOF : 0.3030 (+9.82%)
MMEDF : 4.6900 (+33.24%)
CYBN : 2.16 (-3.14%)
CLXPF : 3.0200 (-1.31%)
AIMLF : 0.5801 (+1.65%)
AIML.CN : 0.750 (unch)
The Weight Loss Tool That Could Help Nearly 1.9 Billion People

The obesity epidemic is still bursting at the seams. At the moment, 1.9 billion people are overweight, ...

CYBN : 2.16 (-3.14%)
CLXPF : 3.0200 (-1.31%)
MMEDF : 4.6900 (+33.24%)
OPTHF : 0.4870 (+3.20%)
FTRP.TO : 5.48 (-5.52%)
FTRP : 4.37 (-4.59%)
NMDBF : 0.0811 (-3.34%)
FTRP.CN : 5.550 (+1.46%)
OPTI.CN : 0.630 (+3.28%)
NEON.CN : 0.105 (unch)
Psilocybin May Be the Key to Resolving the Global Obesity Epidemic

The global obesity issue is bursting at the seams. According to the World Health Organization, obesity ...

CYBN : 2.16 (-3.14%)
CLXPF : 3.0200 (-1.31%)
MMEDF : 4.6900 (+33.24%)
CMPS : 33.14 (-0.66%)
NMDBF : 0.0811 (-3.34%)
TRYP.CN : 0.400 (-1.23%)
NEON.CN : 0.105 (unch)
SpeakEasy Announces Proposed Strategic Acquisition of Karolos Research Inc.

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/

EASY.CN : 0.530 (-1.85%)
CMPS : 33.14 (-0.66%)
MMEDF : 4.6900 (+33.24%)
With Psychedelics, Mental Health Care May Never be the Same

With psychedelics, mental health care may never be the same. All as some of the nation’s “top ...

CYBN : 2.16 (-3.14%)
CLXPF : 3.0200 (-1.31%)
MMEDF : 4.6900 (+33.24%)
CMPS : 33.14 (-0.66%)
NMDBF : 0.0811 (-3.34%)
TRYP.CN : 0.400 (-1.23%)
NEON.CN : 0.105 (unch)
SpeakEasy to Enter Psychedelics Sector with Narcotics Dealers Licence with a Focus on Psilocybin

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/

EASY.CN : 0.530 (-1.85%)
CMPS : 33.14 (-0.66%)
MMEDF : 4.6900 (+33.24%)
Is MindMed a Good Psychedelic Stock to Buy?

A clinical-stage psychedelic medicine biotech company, Mind Medicine Inc. (MMEDF), has benefited from growing demand for therapies for people with mental disorders. However, several headwinds related to...

MMEDF : 4.6900 (+33.24%)
Psychedelics Could Help Treat the 463 Million People Coping with Diabetes

Diabetes is one of the most alarming issues all over the world. At the moment, nearly 463 million ...

MMEDF : 4.6900 (+33.24%)
CMPS : 33.14 (-0.66%)
SEEL : 2.0000 (+1.52%)
CYBN : 2.16 (-3.14%)
CLXPF : 3.0200 (-1.31%)
PHRRF : 0.6498 (-1.55%)
PHRM.CN : 0.840 (+1.20%)
MindMed To Commence Trading on Nasdaq

, /PRNewswire/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have been approved for listing...

MMEDF : 4.6900 (+33.24%)
MNMD : 2.45 (+0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 6.7100
2nd Resistance Point 5.8500
1st Resistance Point 5.2700
Last Price 4.6900
1st Support Level 3.8300
2nd Support Level 2.9700
3rd Support Level 2.3900

See More

52-Week High 5.0700
Last Price 4.6900
Fibonacci 61.8% 3.2445
Fibonacci 50% 2.6806
Fibonacci 38.2% 2.1166
52-Week Low 0.2911

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar